About US
Contact us
-
One, two, three, gone: Teva loses third patent on new Copaxone formulaThree strikes for the patentson Teva Pharmaceutical’s long-acting Copaxone formula: The U.S. Patent and Trademark Office’s review board has now invalidated the third of those patents to come up for re2016/10/11
-
Gilead faces another bid for hep C royalties as U of MN sues for patent infringementThe University of Minnesota wants a piece of Gilead Sciences’ megablockbuster hepatitis C business. The school sued Gilead for patent infringement Monday, claiming that the drugmaker’s sofosbuvir-bas2016/10/10
-
AstraZeneca settles lingering China bribery case with SECAstraZeneca has often been pointed to as a company that knows how to succeed in emerging markets like China, and CEO Pascal Soriot has made growth in these areas as one element of in his 5-part growth2016/10/10
-
Mylan faces more EpiPen scrutiny as House committee demands infoIf Mylan was hoping that its new EpiPen copay assistance and authorized generic would stave off government probing, then it’s hoping in vain. Another congressional commitee has piled on to Mylan and2016/10/9
-
AG lambasts Purdue for fighting his opioid marketing probePurdue Pharma’s highly addictive opioid Oxycontin has led to the company beingmaligned in lawsuits, by law enforcement officials and state and federal lawmakers. Now the Attorney General of New Hampsh2016/10/9
-
Insys sued by Illinois AG for off-label marketing of Subsys opioid sprayAfter a former Insys Therapeutics ($INSY) sales rep admitted she had paid kickbacks to doctors to prescribe the company's sprayed cancer pain opioid fentanyl for off-label uses, it was just a matter o2016/10/8
-
Celgene off-label marketing lawsuit documents unsealedCelgene ($CELG) has successfully fought off several lawsuits suggesting the success of its blockbuster multiple myeloma meds Revlimid and Thalomid relied on aggressive off-label marketing.A California2016/10/8
-
GSK to sell remaining stake in South African drugmaker AspenGlaxoSmithKline (GSK) is planning to divest its remaining stake in South African drugmaker Aspen Pharmacare. The company plans to sell up to 28.2 million ordinary shares in Aspen for a price that wil2016/9/30
-
Kenya launches world's first child-friendly TB medicinesKenya has launched the world's first drug specifically designed to treat tuberculosis (TB) in children. The launch follows a recent pre-qualification by the World Health Organisation to use improved2016/9/30
-
AssistRx and NewCrop to improve capabilities for electronic health recordsUS-based provider of web based pharmaceutical data management solutions AssistRxhas collaborated with local e-prescribing service firm NewCrop to improve capabilities for electronic health records (EH2016/9/29